Brev til redaktøren

• Ekanger, Christian; Helle, Svein Inge; Kvåle, Rune et al. (2024). Reply to M. Kamrava and F. Montorsi et al. (ekstern lenke)
• Gaare, Johannes Jernqvist; Sanchez Nido, Gonzalo; Sztromwasser, Pawel Szymon et al. (2018). No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease. (ekstern lenke)
• Dahl, Olav (2005). Clinical hyperthermia combined with radiation is safe. (ekstern lenke)

Vitenskapelig artikkel

• Overgaard, Jens; CCM Hulshof, Maarten; Dahl, Olav et al. (2024). ESHO 1–85. Hyperthermia as an adjuvant to radiation therapy in the treatment of locally advanced breast carcinoma. A randomized multicenter study by the European Society for Hyperthermic Oncology. (ekstern lenke)
• Overgaard, Jens; Dahl, Olav; Arcangeli, Giorgio (2024). ESHO 2-85. Hyperthermia as an adjuvant to radiation therapy in the treatment of advanced neck nodes: A randomized multicenter study by the European Society for Hyperthermic Oncology. (ekstern lenke)
• Ekanger, Christian; Helle, Svein Inge; Reisæter, Lars Anders Rokne et al. (2024). Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results from a Prospective Study with 7.2 Years of Follow-Up. (ekstern lenke)
• Dahl, Olav; Myklebust, Mette Pernille (2024). A study of microRNAs as new prognostic biomarkers in anal cancer patients. (ekstern lenke)
• Rekeland, Ingrid Gurvin; Sørland, Kari; Neteland, Lisbeth Lykke et al. (2024). Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (ekstern lenke)
• Thor, Anna; Myklebust, Mette Pernille; Bergdahl, Anna Grenabo et al. (2024). miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. (ekstern lenke)
• Rekeland, Ingrid Gurvin; Sørland, Kari; Bruland, Ove et al. (2022). Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. (ekstern lenke)
• Hestetun, Kjersti Elvestad; Rosenlund, Nina Benedikte; Stanisavljevic, Luka et al. (2022). Stage-dependent prognostic shift in mismatch repair-deficient tumors: Assessing patient outcomes in stage II and III colon cancer. (ekstern lenke)
• Berle, Magnus; Hestetun, Kjersti Elvestad; Vethe, Heidrun et al. (2022). Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature. (ekstern lenke)
• Myklebust, Mette Pernille; Søviknes, Anne Mette; Halvorsen, Ole Johan et al. (2022). MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer. (ekstern lenke)
• Aasebø, Kristine Øverås; Bruun, Jarle; Bergsland, Christian Holst et al. (2022). Prognostic role of tumour infiltrating lymphocytes and macrophages in relation to tumour MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients. (ekstern lenke)
• Schem, Baard-Christian; Pfeffer, Frank; Ott, Martin Anton et al. (2022). Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas. (ekstern lenke)
• Hoel, Fredrik; Hoel, August; Pettersen, Ina Katrine Nitschke et al. (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. (ekstern lenke)
• Myklebust, Mette Pernille; Thor, Anna; Rosenlund, Nina Benedikte et al. (2021). Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study. (ekstern lenke)
• Dyrstad, Sissel Elisabeth; Lotsberg, Maria Lie; Tan, Tuan Zea et al. (2021). Blocking aerobic glycolysis by targeting pyruvate dehydrogenase kinase in combination with EGFR TKI and ionizing radiation increases therapeutic effect in non-small cell lung cancer cells. (ekstern lenke)
• Dahl, Olav; Myklebust, Mette Pernille; Dale, Jon Espen et al. (2020). Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version. (ekstern lenke)
• Ekanger, Christian; Helle, Svein Inge; Heinrich, Daniel et al. (2020). Ten-year results from a phase II study on image guided, Intensity Modulated Radiation Therapy with simultaneous integrated boost in high-risk prostate cancer. (ekstern lenke)
• Hestetun, Kjersti Elvestad; Aasebø, Kristine; Rosenlund, Nina Benedikte et al. (2020). Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer. (ekstern lenke)
• Rekeland, Ingrid Gurvin; Fosså, Alexander; Lande, Asgeir et al. (2020). Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study. (ekstern lenke)
• Dale, Jon Espen; Molinelli, Silvia; Vischioni, Barbara et al. (2020). Brainstem NTCP and dose constraints for carbon ion RT—Application and translation from Japanese to European RBE-weighted dose. (ekstern lenke)
• Fjæra, Lars Fredrik; Indelicato, Daniel J.; Ytre-Hauge, Kristian et al. (2020). Spatial agreement of brainstem dose distributions depending on biological model in proton therapy for pediatric brain tumors. (ekstern lenke)
• Fluge, Øystein; Rekeland, Ingrid Gurvin; Lien, Katarina et al. (2019). B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. (ekstern lenke)
• Dale, Jon Espen; Molinelli, Silvia; Vitolo, Viviana et al. (2019). Optic nerve constraints for carbon ion RT at CNAO ? Reporting and relating outcome to European and Japanese RBE. (ekstern lenke)
• Myklebust, Mette Pernille; Rosenlund, Nina Benedikte; Gjengstø, Peder et al. (2019). Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis. (ekstern lenke)
• Dahl, Olav; Dale, Jon Espen; Brydøy, Marianne (2018). Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment. (ekstern lenke)
• Gaare, Johannes Jernqvist; Sanchez Nido, Gonzalo; Sztromwasser, Pawel Szymon et al. (2018). Rare genetic variation in mitochondrial pathways influences the risk for parkinson's disease. (ekstern lenke)
• Haugnes, Hege Sagstuen; Stenklev, Niels Christian; Brydøy, Marianne et al. (2018). Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study. (ekstern lenke)
• Guren, Marianne; Aagnes, Bjarte; Nygård, Mari et al. (2018). Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016. (ekstern lenke)
• Jacob, Havjin; Stanisavljevic, Luka; Storli, Kristian Eeg et al. (2018). A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer. (ekstern lenke)
• Jacob, Havjin; Stanisavljevic, Luka; Storli, Kristian Eg et al. (2017). Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. (ekstern lenke)
• Dale, Jon Espen; Molinelli, Silvia; Ciurlia, Elisa et al. (2017). Risk of carotid blowout after reirradiation with particle therapy. (ekstern lenke)
• Fjæra, Lars Fredrik; Li, Zuofeng; Ytre-Hauge, Kristian et al. (2017). Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer. (ekstern lenke)
• Lunde, Sigrid; Kristoffersen, Einar Klæboe; Sapkota, Dipak et al. (2016). Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. (ekstern lenke)
• Tandstad, Torgrim; Ståhl, Olof; Dahl, Olav et al. (2016). Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). (ekstern lenke)
• Dale, Jon Espen; Sebjørnsen, Sigrunn; Leh, Sabine Maria et al. (2016). Multimodal therapy is feasible in elderly anal cancer patients. (ekstern lenke)
• Pedersen, Kjetil Boye; Jacob, Havjin; Frikstad, Kari-Anne et al. (2016). Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy. (ekstern lenke)
• Stanisavljevic, Luka; Myklebust, Mette Pernille; Leh, Sabine Maria et al. (2016). LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. (ekstern lenke)
• Fluge, Øystein; Mella, Olav; Bruland, Ove et al. (2016). Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.. (ekstern lenke)
• Dahl, Alv A; Østby-Deglum, Marie; Oldenburg, Jan et al. (2016). Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings. (ekstern lenke)
• Sakkestad, Sunniva Todnem; Olsen, Bjørn Christian Elias Grova; Karliczek, Anne et al. (2015). Validity of Norwegian Rectal Cancer Registry data at a major university hospital 1997-2005. (ekstern lenke)
• Tandstad, Torgrim; Solberg, Arne; Håkansson, Ulf et al. (2015). Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. (ekstern lenke)
• Guren, Marianne; Kørner, Hartwig; Pfeffer, Frank et al. (2015). Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. (ekstern lenke)
• Stanisavljevic, Luka; Assmus, Jörg; Storli, Kristian Eg et al. (2015). CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer. (ekstern lenke)
• Fluge, Øystein; Risa, Kristin; Lunde, Sigrid et al. (2015). B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. (ekstern lenke)
• Hestetun, Kjersti Elvestad; Brydøy, Marianne; Myklebust, Mette Pernille et al. (2015). Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer. (ekstern lenke)
• Leon, Otilia; Guren, Marianne; Hagberg, Oskar et al. (2014). Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines. (ekstern lenke)
• Tandstad, Torgrim; Ståhl, Olof; Håkansson, Ulf et al. (2014). One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group. (ekstern lenke)
• Bentzen, Anne Gry; Guren, Marianne; Vonen, Barthold et al. (2013). Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort. (ekstern lenke)
• Andreassen, Kristine Engen; Kristiansen, Wenche; Karlsson, Robert et al. (2013). Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor. (ekstern lenke)
• Karlsson, Robert; Andreassen, Kristine Engen; Kristiansen, Wenche et al. (2013). Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4. (ekstern lenke)
• Bentzen, Anne Gry; Balteskard, Lise; Wanderås, Eva Hoff et al. (2013). Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors. (ekstern lenke)
• Kristiansen, Wenche; Andreassen, Kristine Engen; Karlsson, Robert et al. (2012). Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. (ekstern lenke)
• Rades, Dirk; Setter, Cornelia; Dahl, Olav et al. (2012). Fibroblast growth factor 2—A predictor of outcome for patients irradiated for stage II-III non–small-cell lung cancer. (ekstern lenke)
• Rades, Dirk; Setter, Cornelia; Dahl, Olav et al. (2012). The prognostic impact of tumor cell expression of estrogen receptor-alpha, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer. (ekstern lenke)
• Myklebust, Mette Pernille; Fluge, Øystein; Immervoll, Heike et al. (2012). Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. (ekstern lenke)
• Haugnes, Hege Sagstuen; Laurell, Anna; Stierner, Ulrika et al. (2012). High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA). (ekstern lenke)
• Westermann, Anneke; Mella, Olav; Van der Zee, Jacoba et al. (2012). Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie Dorothea; Klepp, Olbjørn et al. (2012). Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. (ekstern lenke)
• Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H. et al. (2012). Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. (ekstern lenke)
• Tveit, Magne Kjell; Guren, Tormod Kyrre; Glimelius, Bengt et al. (2012). Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII Study. (ekstern lenke)
• Bentzen, Anne Gry; Guren, Marianne; Wanderås, Eva Hoff et al. (2012). Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort. (ekstern lenke)
• Tandstad, Torgrim; Smaaland, Rune; Solberg, Arne et al. (2011). Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group. (ekstern lenke)
• Balteskard, Lise; Dahl, Olav; Guren, Marianne et al. (2011). Faglige anbefalinger for behandling ved analcancer. (ekstern lenke)
• Myklebust, Mette Pernille; Bruland, Ove; Fluge, Øystein et al. (2011). MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. (ekstern lenke)
• Fluge, Øystein; Bruland, Ove; Risa, Kristin et al. (2011). Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. (ekstern lenke)
• Rades, Dirk; Setter, Cornelia; Dahl, Olav et al. (2011). Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer. (ekstern lenke)
• Olofsson, Sven-Erik; Tandstad, Torgrim; Jerkeman, Mats et al. (2011). Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian testicular cancer group. (ekstern lenke)
• Kvåle, Rune; Møller, Bjørn; Angelsen, Anders et al. (2010). Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007. (ekstern lenke)
• Dahl, Christian Falk; Haugnes, Hege Sagstuen; Bremnes, Roy M. et al. (2010). A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors. (ekstern lenke)
• Haugnes, Hege Sagstuen; Wethal, Torgeir; Aass, Nina Kathrine et al. (2010). Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. (ekstern lenke)
• Bruheim, K; Guren, MG; Skovlund, E et al. (2010). Late side effects and quality of life after radiotherapy for rectal cancer. (ekstern lenke)
• Tandstad, Torgrim; Cohn-Cedermark, Gabriella; Dahl, Olav et al. (2010). Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. (ekstern lenke)
• Rades, Dirk; Setter, Cornelia; Dunst, Jürgen et al. (2010). Prognostic Impact of VEGF and VEGF Receptor 1 (FLT1) Expression in Patients Irradiated for Stage II/III Non-Small Cell Lung Cancer (NSCLC). (ekstern lenke)
• Li, Zhiping; Jiao, Xuanmao; Wang, Chenguang et al. (2010). Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie D; Klepp, Olbjørn et al. (2010). Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy. (ekstern lenke)
• BRUHEIM, KJERSTI; Guren, Marianne; Skovlund, Eva et al. (2010). Late side effects and quality of life after radiotherapy for rectal cancer. (ekstern lenke)
• Rutskij, Robert; Gaarden, Torfinn; Bremnes, R et al. (2010). A study of coping in long-term testicular cancer survivors. (ekstern lenke)
• Brydøy, Marianne; Oldenburg, Jan; Klepp, Olbjørn et al. (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. (ekstern lenke)
• Dahl, Olav; Fluge, Øystein; Carlsen, Erik et al. (2009). Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. (ekstern lenke)
• Bass, Adam J; Watanabe, Hideo; Mermel, Craig et al. (2009). SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. (ekstern lenke)
• Fluge, Øystein; Gravdal, K; Carlsen, E et al. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. (ekstern lenke)
• Tandstad, T; Dahl, Olav; Cohn-Cedermark, G et al. (2009). Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program. (ekstern lenke)
• Haugnes, Hege Sagstuen; Aass, Nina; Fosså, Sophie D et al. (2009). Pulmonary Function in Long-Term Survivors of Testicular Cancer. (ekstern lenke)
• Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove et al. (2009). Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. (ekstern lenke)
• Sigurdsson, Helgi Kjartan; Søreide, Jon Arne; Dahl, Olav et al. (2009). Utilisation of specialist care in patients with incurable rectal cancer. A population-based study from Western Norway. (ekstern lenke)
• Grov, EK; Grov, EK; Fossa, SD et al. (2009). The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav (2009). Topographical distribution of choroidal naevi in the ocular fundus. (ekstern lenke)
• Overgaard, Jens; Gonzalez-Gonzales, Dionisio; Hulshof, Maarten C.C.H. et al. (2009). Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicenter randomized trial by The European Society for Hyperthermic Oncology. (ekstern lenke)
• Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav et al. (2009). Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. (ekstern lenke)
• Jullumstrø, Eivind; Lydersen, Stian; Møller, Bjørn et al. (2009). Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer. (ekstern lenke)
• Brydøy, Marianne; Oldenburg, Jan; Oldenburg, J et al. (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. (ekstern lenke)
• Borkamo, Erling Dahl; Schem, Baard-Christian; Fluge, Øystein et al. (2009). cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapy. (ekstern lenke)
• Skaali, Tone; Skaali, T; Fossa, SD et al. (2009). Fear of recurrence in long-term testicular cancer survivors. (ekstern lenke)
• Karlsdóttir, Ása; Muren, Ludvig Paul; Wentzel-Larsen, Tore et al. (2009). Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. (ekstern lenke)
• Røe, Kathrine; Muren, Ludvig Paul; Rørvik, Jarle et al. (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. (ekstern lenke)
• Røe, Kathrine; Muren, Ludvig; Rørvik, Jarle et al. (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. (ekstern lenke)
• Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove et al. (2008). Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. (ekstern lenke)
• Skaali, T; Fosså, Sophie Dorothea; Bremnes, R et al. (2008). Fear of recurrence in long-term testicular cancer survivors. (ekstern lenke)
• Haugnes, Hege Sagstuen; Aass, Nina; Fosså, SD et al. (2008). Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Dahl, Olav (2008). Incidence of iris melanoma in western Norway. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Monge, Odd R.; Skorpen, Tone Nybø et al. (2008). Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation. (ekstern lenke)
• Karlsdóttir, Ása; Muren, Ludvig Paul; Wentzel-Larsen, T. et al. (2008). Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav (2008). Posterior uveal melanoma. Distribution of the sites of origin and patterns of tumour extent in the ocular fundus. (ekstern lenke)
• Haugnes, Hege Sagstuen; Aass, Nina; Fosså, Sophie D et al. (2008). Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. (ekstern lenke)
• Orre, IJ; Fosså, Sophie Dorothea ; Fossa, SD et al. (2008). Chronic cancer-related fatigue in long-term survivors of testicular cancer. (ekstern lenke)
• Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav et al. (2008). Palliative surgery for rectal cancer in a national cohort. (ekstern lenke)
• Bruland, Ove; Fluge, Øystein; Immervoll, Heike et al. (2008). Gene expression reveals two distinct groups of anal carcinomas with clinical implications. (ekstern lenke)
• Dahl, Olav; Borkamo, Erling Dahl; Fluge, Øystein (2008). Current status of antivascular therapy and targeted treatment in the clinic. (ekstern lenke)
• Borkamo, Erling Dahl; Fluge, Øystein; Mella, Olav et al. (2008). Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. (ekstern lenke)
• Dahl, Olav (2007). Adjuvant kjemoterapi ved tykktarmskreft. (ekstern lenke)
• Balteskard, L; Vonen, Barthold; Frykholm, Gunilla et al. (2007). Strålebehandling av endetarmskreft. (ekstern lenke)
• Brydoy, M; Brydøy, Marianne; Fosså, Sophie D. et al. (2007). Gonadal dysfunction and fertility problems in cancer survivors. (ekstern lenke)
• Larsen, Annette; Bronstein, Igor B.; Dahl, Olav et al. (2007). Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin. (ekstern lenke)
• Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav et al. (2007). Clinical characteristics and outcomes in patients with advanced rectal cancer: A national prospective cohort study. (ekstern lenke)
• Dahl, Alv A; Bremnes, Roy M.; Dahl, Olav et al. (2007). Is the sexual function compromised in long-term testicular cancer survivors?. (ekstern lenke)
• Sagstuen, hege; Aass, N; Fossa, SD et al. (2007). Components of the metabolic syndrome in long-term survivors of testicular cancer. (ekstern lenke)
• Brydøy, Marianne; Storstein, Anette Margrethe; Dahl, Olav (2007). Transient neurological adverse effects following low dose radiation therapy for early stage testicular seminoma. (ekstern lenke)
• Larsen, Annette; Bjørge, Benedikte; Klementsen, Beate et al. (2007). Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. (ekstern lenke)
• Sagstuen, hege; Aass, N; Fosså, Sophie D et al. (2006). Components of the metabolic syndrome in long-term survivors of testicular cancer. (ekstern lenke)
• Muren, Ludvig Paul; Redpath, Anthony Thomas ; McLaren, Duncan et al. (2006). A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. (ekstern lenke)
• Karlsdottir, A; Muren, Ludvig Paul; Wentzel-Larsen, T. et al. (2006). Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie D; Klepp, Olbjørn et al. (2005). Paternity following treatment for testicular cancer. (ekstern lenke)
• Mykletun, A; Dahl, Alv A; Haaland, Carl Fredrik et al. (2005). Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. (ekstern lenke)
• Thorsen, L; Nystad, W; Dahl, Olav et al. (2005). The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. (ekstern lenke)
• Thorsen, L; Nystad, W; Stigum, H et al. (2005). The assosiation between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men i general population sample. (ekstern lenke)
• Brydoy, M; Fossa, SD; Klepp, Olbjørn et al. (2005). Paternity following treatment for testicular cancer. (ekstern lenke)
• Hovdenak, Nils; Sørbye, Halfdan; Dahl, Olav (2005). SSucralfate does not ameliorate acute radiation proctitis: Randomised study and meta-analysis. (ekstern lenke)
• Sagstuen, Hege; Aass, Nina; Fosså, Sophie D et al. (2005). Blood pressure and body mass index in long-term survivors of testicular cancer. (ekstern lenke)
• Dahl, Alv A; Haaland, Carl Fredrik; Mykletun, Anstein et al. (2005). Study of anxiety disorder and depression in long-term survivors of testicular cancer. (ekstern lenke)
• Glimelius, B; Dahl, O; Cedermark, B et al. (2005). Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. (ekstern lenke)
• Brydøy, M; Fosså, Sophie Dorothea; Klepp, Olbjørn et al. (2005). Paternity following treatment for testicular cancer. (ekstern lenke)
• Thorsen, Lene; Nystad, Wenche; Stigum, Hein et al. (2005). The association between self-reported physical activity and prevalence of depression and anxiety disorders in long-term survivors of testicular cancer and men in the general population sample. (ekstern lenke)
• Muren, Ludvig Paul; Karlsdóttir, Ása; Wentzel-Larsen, Tore et al. (2005). Testing the new ICRU 62 'Planning Organ at Risk Volume' concept for the rectum. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie D.; Klepp, Olbjørn et al. (2005). Paternity Following Treatment for Testicular Cancer. (ekstern lenke)
• Glimelius, Bengt; Dahl, Olav; Cedermark, Björn et al. (2005). Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. (ekstern lenke)
• Muren, Ludvig Paul; Ekerold, R; Kvinnsland, Yngve et al. (2004). On the use of margins for geometrical uncertainties around the rectum in radiotherapy planning. (ekstern lenke)
• Sørbye, Halfdan; Dahl, Olav (2004). Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer. (ekstern lenke)
• Kvinnsland, Yngve; Muren, Ludvig Paul; Dahl, Olav (2004). A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of equivalent uniform doses and the volume parameter. (ekstern lenke)
• Larsen, Annette; Hovdenak, Nils; Karlsdottir, Åsa et al. (2004). Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: A pilot study of eight stool markers. (ekstern lenke)
• Dahl, Olav; Aarseth, J; Myhr, Kjell-Morten et al. (2004). Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. (ekstern lenke)
• Eikesdal, Hans Petter; Straume, Oddbjørn; Akslen, Lars A. et al. (2004). Karnydanning og tumorkar som mål for kreftterapi. (ekstern lenke)
• Karlsdottir, Åsa; Johannessen, Dag Clement; Muren, Ludvig Paul et al. (2004). Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. (ekstern lenke)
• Sørbye, Halfdan; Glimelius, Bengt; Berglund, Å et al. (2004). Multicentre phase II study of Nordic 5-fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. (ekstern lenke)
• Kvinnsland, Yngve; Muren, Ludvig Paul; Dahl, Olav (2004). Evaluation of a new method for calculation of cumulative doses in the rectum wall using repeat CT scans. (ekstern lenke)
• Baumann, M; Leer, J.W.H.; Dahl, Olav et al. (2004). Updated European core curriculum for radiotherapists (radiation oncologists). Recommended curriculum for the specialist training of medical practitioners in radiotherapy (radiation oncology) within Europe. (ekstern lenke)
• Sagstuen, Hege; Aass, Nina Kathrine; Fosså, Sophie Dorothea et al. (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors. (ekstern lenke)
• Muren, Ludvig Paul; Småland, Rune; Dahl, Olav (2004). Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. (ekstern lenke)
• Thorsen, L; Nystad, W; Dahl, Olav et al. (2003). The level of physical activity in long-term surdivors of testicular cancer. (ekstern lenke)
• Nord, C; Ellingsen, D; Mykletun, A et al. (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. (ekstern lenke)
• Arnesen, Harald; Dahl, O; Aspelin, Trude et al. (2003). Sustained Prothrombotic profile after Hip Replacement Surgery. The Influence of Prolonged Prophylaxis with Dalteparin. (ekstern lenke)
• Ellingsen, D; Mykletun, Arnstein; Dahl, O et al. (2003). Gonadal hormones in longterm survivors 10 years after treatment for unilateral testicular cancer. (ekstern lenke)
• Nord, Carina; Bjøro, Trine; Ellingsen, D et al. (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. (ekstern lenke)
• Kristiansen, Ivar Sønbø; Norderhaug, Inger; Bjerklund Johansen, Truls et al. (2003). Brachytherapy for prostatic cancer: a systematic review of clinical and cost effectiveness. (ekstern lenke)
• Hovdenak, Nils; Karlsdottir, Åsa; Sørbye, Halfdan et al. (2003). Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate. (ekstern lenke)
• Norderhaug, Inger; Dahl, Olav; Høisæter, Per Å. et al. (2003). Brachytherapy for prostate cancer: A systematic review of clinical and cost effectiveness. (ekstern lenke)
• Sørbye, Halfdan; Dahl, Olav (2003). Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to Oxaliplatin combination chemotherapy: Implications for tumor marker monitoring and guidelines. (ekstern lenke)
• Thorsen, Lene; Nystad, Wenche; Dahl, Olav et al. (2003). The level of physical activity in long-term survivors of testicular cancer. (ekstern lenke)
• Nord, Carina; Bjøro, Trine; Ellingsen, Dag et al. (2003). Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. (ekstern lenke)
• Muren, Ludvig; Småland, Rune; Dahl, Olav (2003). Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. (ekstern lenke)
• Sørbye, Halfdan; Dahl, Olav (2003). Nordic 5-Fluorouracil/Leucovorin bolus schedule combined with Oxaliplatin (Nordic FLOX)as first-line treatment of metastatic colorectal cancer. (ekstern lenke)
• Norderhaug, Inger; Johansen, Truls Bjerklund; Dahl, Olav et al. (2002). Brakyterapi ved prostatakreft. (ekstern lenke)
• Muren, Ludvig; Mella, Olav; Hafslund, Rune et al. (2002). Norwegian Oncologists' Expectations of Intensity-modulated Radiotherapy. (ekstern lenke)
• Eikesdal, Hans Petter; Bjørkhaug, Steinar T.; Dahl, Olav (2002). Hyperthermia exhibits anti-vascular activity in the s.c. BT4An rat glioma: lack of interaction with the angiogenesis inhibitor batimastat. (ekstern lenke)
• Muren, Ludvig; Maurstad, Gjertrud; Hafslund, Rune et al. (2002). Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. (ekstern lenke)
• Eikesdal, Hans Petter; Landuyt, Willy; Dahl, Olav (2002). The influence of combretastatin A-4 and vinblastine on interstitial fluid pressure in BT4An rat gliomas. (ekstern lenke)
• Muren, Ludvig; Maurstad, Gjertrud; Hafslund, Rune et al. (2001). Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. (ekstern lenke)
• Sørbye, Halfdan; Bruserud, Øystein; Dahl, Olav (2001). Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and hemolysis. Case report. (ekstern lenke)
• Knutsen, S; Hafslund, Rune; Monge, Odd R et al. (2001). Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy. (ekstern lenke)
• Eikesdal, Hans Petter; Bjerkvig, Rolf; Mella, Olav et al. (2001). Combretastatin A-4 and hyperthermia; a potent combination for the treatment of solid tumors. (ekstern lenke)
• Muren, Ludvig; Hafslund, Rune; Gustafsson, Anders et al. (2001). Partially wedged beams improve radiotherapy treatment of urinary bladder cancer. (ekstern lenke)
• Eikesdal, Hans Petter; Bjerkvig, Rolf; Dahl, Olav (2001). Vinblastine and hyperthermia target the neovasculature in BT(4)AN rat gliomas: therapeutic implications of the vascular phenotype. (ekstern lenke)
• Eikesdal, Hans Petter; Bjerkvig, Rolf; Raleigh, James A. et al. (2001). Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia. (ekstern lenke)
• Dahl, Olav; Fellespubl., [Mangler fornavn] (2001). Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. (ekstern lenke)
• Muren, Ludvig; Jebsen, Nina; Gustafsson, Anders et al. (2001). Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters. (ekstern lenke)
• Fosså, Sophie Dorothea; Aass, Nina; Tveter, Kjell et al. (2000). Behandling av nyrekreft med fjernmetastaser. (ekstern lenke)
• Fosså, Sophie D.; Aass, N; Tveter, K et al. (2000). Behandling av nyrekreft med fjernmetastaser. (ekstern lenke)
• Bernier, J; Denekamp, J; Rojas, A et al. (2000). ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC). (ekstern lenke)
• Muren, Ludvig; Hafslund, Rune; Dahl, Olav (2000). Partially wedged fields formed by dynamic collimation. (ekstern lenke)
• Eikesdal, Hans Petter; Schem, Baard-Christian; Mella, Olav et al. (2000). The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma. (ekstern lenke)
• Theodrou, K; Platoni, K; Lefkopoulos, D et al. (2000). Dose-volume analysis of different stereotactic radiotherapy mono-isocentric techniques. (ekstern lenke)
• Muren, Ludvig; Hafslund, Rune; Valen, Harald et al. (2000). Adapting the waterproof BMS-96 diode array for isodose measurements of intensity modulated beams. (ekstern lenke)
• Fosså, Sophie D.; Aass, N.; Tveter, K. et al. (2000). Behandling av nyrekreft med fjernmetastaser. (ekstern lenke)
• Muren, Ludvig Paul; Hafslund, Rune; Dahl, Olav (2000). Partially wedged fields formed by dynamic collimation. (ekstern lenke)
• Muren, Ludvig Paul; Hafslund, Rune; Valen, Harald et al. (2000). Adapting the waterproof BMS-96 diode array for isodose measurements of intensity modulated beams. (ekstern lenke)
• Theodrou, K.; Platoni, K.; Lefkopoulos, D. et al. (2000). Dose-volume analysis of different stereotactic radiotherapy mono-isosentric techniques. (ekstern lenke)
• Eikesdal, Hans Petter; Schem, Baard Christian; Mella, Olav et al. (2000). The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma. (ekstern lenke)
• Bernier, J.; Denekamp, J.; Rojas, A. et al. (2000). ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC). (ekstern lenke)
• Øgreid, Per; Fosså, Sophie D.; Berner, AA et al. (1999). Tissue PSA and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy. (ekstern lenke)
• Øgreid, Per Ingvar; Berner, Aasmund; Dahl, Olav et al. (1999). Tissue Prostate-Specific Antigen and Androgen Receptor Immunoreactivity in Prostate Cancer Biopsies before, during and after Neo-Adjuvant Androgen Deprivation Followed by Radiotherapy. (ekstern lenke)
• Bernier, J; Denekamp, J; van Glabbeke, M et al. (1999). ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by EORTC. (ekstern lenke)
• Dahl, Olav; Dalene, Ronny; Schem, Baard Christian et al. (1999). Status of clinical hyperthermia. (ekstern lenke)
• Øgreid, Per; Berner, AA; Dahl, Olav et al. (1999). Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy. (ekstern lenke)
• Sørbye, Halfdan; Jensen, Dag; Dahl, Olav (1998). Lymphocele after retroperitoneal surgery for testicular or extragonadal germ cell tumors may mimic recurrence. (ekstern lenke)
• Sørbye, Halfdan; Jensen, Dag; Dahl, Olav (1998). Lymphocele after retroperitoneal surgery for testicular or extragonadal germ cell tumors may mimic recurrence. (ekstern lenke)
• Lilleng, PK; Monge, OR; Walløe, A et al. (1997). Fibrosarcoma in children. A rare tumour with long-term survival even with advanced disease. A report of 3 cases. (ekstern lenke)
• Klepp, O; Dahl, Olav; Flodgren, P et al. (1997). for the Swedish-Norwegian Testis Cancer Group (SWENOTECA). (ekstern lenke)
• Klepp, O; Dahl, Olav; Flodgren, P et al. (1997). Risk-adapted treatment of clinical stage I nonseminoma testis cancer. (ekstern lenke)
• Kolitsi, Z; Dahl, Olav; Van, Loon R et al. (1997). Quality assurance in conformal radiotherapy. DYNARAD consensus report on pratice guidelines. (ekstern lenke)
• Terzis, AJ; Thorsen, Frode; Heese, O et al. (1997). Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. (ekstern lenke)
• Lilleng, Peer Kåre; Monge, Odd R; Walløe, Anders et al. (1997). Fibrosarcoma in children. (ekstern lenke)
• Klepp, O.; Dahl, O; Flodgren, P et al. (1997). Risk-adapted treatment of clinical stage I non-seminaoma testis cancer. (ekstern lenke)
• Dahl, Olav; Kardamakis, D; Lind, B et al. (1996). Clinical assessment of conformal radiotherapy results. (ekstern lenke)
• Dahl, Olav; Vagstad, Geirfinn; Iversen, Bjarne Magnus (1996). Cisplatin-based chemotherapy in a renal transplant recipient with metastatic germ cell testicular cancer. (ekstern lenke)
• Krossnes, Bård Kronen; Mella, Olav; Dahl, Olav (1996). Use of the vasodilator sodium nitroprusside during local hyperthermia: Effects on tumor temperature and tumor response in a rat tumor model. (ekstern lenke)
• Risberg, T; Lund, Erik; Wist, E et al. (1995). The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. (ekstern lenke)
• Overgaard, J; Gonzalez Gonzalez, D; Hulshof, MCCM et al. (1995). Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. (ekstern lenke)
• Bakkevold, Kåre; Arnesjø, Bo; Dahl, Olav et al. (1993). Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater - Results of a controlled, prospective, randomised multicentre study. (ekstern lenke)
• Ly, B; Solum, NO; Vennerød, AM et al. (1978). A syndrome of factor VVI deficiency and abnormal platelet release reaction. (ekstern lenke)

Leder

• Dahl, Olav (2022). Watch your steps, especially when changing treatment for locally advanced rectal cancer. (ekstern lenke)
• Dahl, Olav; Brydøy, Marianne (2019). The pioneers behind immune checkpoint blockers awarded the Nobel Prize in physiology or medicine 2018. (ekstern lenke)
• Dahl, Olav; Pfeffer, Frank (2015). Twenty-five years with adjuvant chemotherapy for colon cancer--a continuous evolving concept.. (ekstern lenke)
• Dahl, Olav; Brydøy, Marianne (2012). Testicular germ cell tumours - still many challenges. (ekstern lenke)
• Dahl, Olav (2009). Follow up your unexpected clinical observations!. (ekstern lenke)
• Dahl, Olav (2005). Protons. A step forward or perhaps only more expensive radiation therapy?. (ekstern lenke)
• Dahl, Olav (2005). First things first. (ekstern lenke)

Doktorgradsavhandling

• Jacob, Havjin; Dahl, Olav (2018). Prognostic biomarkers in stage II and III colorectal cancer: A study with focus on microRNAs and S100A4. (ekstern lenke)
• Stanisavljevic, Luka; Dahl, Olav (2016). Molecular and clinicopathological factors with emphasis on prognostic and predictive factors for survival. (ekstern lenke)
• Larsen, Annette; Dahl, Olav (2007). Inflammatory biomarkers with focus on Calprotectin (S100A8/S100A9) and S100A12 (EN-RAGE) : method development and application in acute radiation proctitis and rheumatoid arthritis patients. (ekstern lenke)
• Hovdenak, Nils; Dahl, Olav (2004). Acute radiation proctitis: a clinical, histopathological and histochemical study. (ekstern lenke)
• Dahl, Olav (1983). Experimental hypothermia in a neurogenic rat tumour : combi- nation with cytotoxic drugs. (ekstern lenke)

Fagartikkel

• Skrede, Steinar; Dahl, Olav (2017). Hybrid mellom søstermarihand Dactylorhiza sambucina og skogmarihand Dactylorhiza maculata subsp. fuchsii i Telemark. . (ekstern lenke)

Fagbok

• Dahl, Olav; Lehne, Gustav; Christoffersen, Thoralf (2016). Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. (ekstern lenke)
• Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg et al. (2009). Medikamentell kreftbehandling. Cytostatikaboken. 7. utgave. (ekstern lenke)
• Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg et al. (2009). Medikamentell kreftbehandling. Cytostatikaboken. (ekstern lenke)
• Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg et al. (2009). Medikamentell kreftbehandling. (ekstern lenke)
• Dahl, Olav; Lehne, Gustav; Baksaas, Ingebjørg et al. (2009). Medikamentell kreftbehandling. Cytostatikaboken. (ekstern lenke)
• Dahl, O; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Medikamentell kreftbehandling. 6 utgave 1999. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Mendikamentell kreftbehandling. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Skarstein, Arne; Tveit, Kjell Magne; Bergan, A. et al. (1998). Standardprogram ved colorectalcancer. (ekstern lenke)

Faglig kapittel

• Dahl, Olav; Kvaløy, Stein Olav; Lehne, Gustav et al. (2016). Medikamentell kreftbehandling. (ekstern lenke)
• Christoffersen, Thoralf; Bruserud, Øystein; Fluge, Øystein et al. (2016). Kreftbiologi og medikamentell terapi. (ekstern lenke)
• Dahl, Olav; Nygaard, Randi; Brydøy, Marianne et al. (2016). Bivirkninger. (ekstern lenke)

Leserinnlegg

• Oldenburg, Jan; Haugnes, Hege Sagstuen; Dahl, Olav et al. (2015). Behandling ved stadium I-testikkelkreft bør vurderes individuelt. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Dahl, Olav; Nybø, Tone et al. (2014). J. Krohn og medarbeidere svarer. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav (2009). Topography of solitary congenital hypertrophy of the retinal pigment epithelium in the ocular fundus. (ekstern lenke)
• Dahl, Olav (2008). 2008 ESHO-BSD award winner - Gerard C. van Rhoon. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Dahl, Olav (2008). Incidence of iris melanoma in western Norway. (ekstern lenke)
• Dahl, Olav; Mella, Olav (2002). Hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer. (ekstern lenke)

Sammendrag/abstract

• Grotmol, Tom; Karlsson, Robert; Kristiansen, Wenche et al. (2014). Scandinavian studies of gene variants and risk of testicular germ cell tumor. (ekstern lenke)
• Waldeland, Einar; Dahl, Olav; Odland, Odd Harald et al. (2014). Particle therapy in Norway - report from the national project group. (ekstern lenke)
• Grotmol, Tom; Karlsson, Robert; Kristiansen, Wenche et al. (2013). Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in the tumor suppressor gene SPRY4. (ekstern lenke)
• Tandstad, Torgrim; Solberg, Arne; Håkansson, Ulf et al. (2012). Bilateral testicular cancer within two prospective, population-based SWENOTECA protocols in clinical stage I nonseminoma. (ekstern lenke)
• Olofsson, Sven-Erik; Dahl, Olav; Jerkeman, Mats et al. (2009). Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav (2008). Topographical distribution of posterior uveal melanoma, choroidal nevi, and congenital hypertrophy of the retinal pigment epithelium. (ekstern lenke)
• Sigurdsson, Helgi Kjartan; Kørner, Hartwig; Dahl, Olav et al. (2008). Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. (ekstern lenke)
• Haugnes, Hege Sagstuen; Aass, Nina; Fosså, Sophie D et al. (2008). Pulmonary function in long-term testicular cancer survivors. (ekstern lenke)
• Skaali, T; Fossa, SD; Bremnes, Roy M. et al. (2007). Fear of recurrence in long-term testicular cancer survivors. (ekstern lenke)
• Bremnes, Roy M.; Grov, Ellen Karine ; Klepp, O et al. (2007). Is neuroticism associated with long-term morbidity in testicular cancer survivors?. (ekstern lenke)
• Brydøy, Marianne; oldenburg, j; Klepp, Olbjørn et al. (2006). Self-reported paresthesia, Raynaud,s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. (ekstern lenke)
• Bremnes, Roy M.; Sagstuen, hege; Aass, N et al. (2006). Cardiovascular (CV)morbidity and predicted mortality in long-term testicular cancer (TC) survivors. (ekstern lenke)
• Brydøy, Marianne; Oldenburg, Johannes; Klepp, Olbjørn et al. (2006). Self-reported paresthesias, Raynaud's phenomena, tinnitus, and hearing impairment in a large cohort of long-term testicular cancer (TG) survivors. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie D.; Bremnes, Roy et al. (2005). Gonadal hormones, sperm counts and post-treatment paternity in long-term survivors of unilateral testicular cancer. (ekstern lenke)
• Brydøy, Marianne; Fosså, SS; Bremnes, Roy M. et al. (2005). Self-reported paresthesia, Raynaud’s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. (ekstern lenke)
• Sagstuen, Hege; Aass, Nina; Aass, Nina Kathrine et al. (2005). Metabolic syndrome in long-term testicular cancer survivors. (ekstern lenke)
• Sagstuen, Hege; Aass, Nina; Fosså, Sophie D et al. (2005). Metabolic syndrome in long-term testicular cancer survivors. (ekstern lenke)
• Sagstuen, Hege; Aass, N; Fosså, Sophie D et al. (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors. (ekstern lenke)
• Brydøy, Marianne; Fossa, S; Klepp, Olbjørn et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie D; Klepp, Olbjørn et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Balteskard, L; Bremnes, Roy M.; Dahl, O et al. (2004). Working ability and educational level among long-term survivors of teasticular cancer (TCSS) compared to a general population (GenPop). (ekstern lenke)
• Muren, Ludvig Paul; Karlsdottir, Åsa; Kvinnsland, Yngve et al. (2004). Testing the new ICRU 62 'planning organ at risk volume' concept for the rectum. (ekstern lenke)
• Klepp, Olbjørn; Dahl, Olav; Cavallin-Stahl, E et al. (2003). Risk-adapted brief adjuvant chemotherapy in clinical stage I (CSI) nonseminomatous germ cell testicular cancer (NSGCT). (ekstern lenke)
• Muren, Ludvig Paul; Ekerold, R; Småland, Rune et al. (2003). Treatment precision and treatment effect in conformal radiotherapy of urinary bladder cancer - preliminary results. (ekstern lenke)

Vitenskapelig foredrag

• Tandstad, Torgrim; Stahl, E.; Dahl, Olav et al. (2014). Management of clinical stage I seminomatous testicular cancer: A report from SWENOTECA. (ekstern lenke)
• Dahl, Olav (2006). The present conditions and the future prospects of clinical test of hyperthermia in Europe. (ekstern lenke)
• Krohn, Jørgen Gitlesen; Frøystein, Torbjørn; Dahl, Olav (2006). Posterior uveal melanoma. Distribution of initiation sites and patterns of tumour extent in the ocular fundus. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie D.; Bremnes, Roy et al. (2005). Gonadal hormones, sperm counts and post-treatment paternity in long-term survivors of unilateral testicular cancer. (ekstern lenke)
• Glimelius, Bengt; Sørbye, Halfdan; Balteskard, L et al. (2005). A randomised phase III multicenter trial comparing irinotecan in combination with 5FU and folinic acid (FU/FA) given according to the Nordic bolus schedule to irinotecan in combination with 5FU/FA given according to the bolus/infused de Gramont schedule, in patients with metastatic colorectal cancer. (ekstern lenke)
• Muren, Ludvig Paul; Redpath, Anthony Thomas; Mclaren, D et al. (2005). A concomitant tumour boost in bladder irradiation: Patient suitability and the potensial of intensity-modulated radiotherapy. (ekstern lenke)
• Dahl, Olav (2005). Får pasienter med lokalisert prostatakreft adekvat tilbud om radikal strålebehandling?. (ekstern lenke)
• Sagstuen, Hege; Aass, Nina; Fosså, Sophie D. et al. (2004). Blood pressure and body mass index (BMI) in testicular cancer survivors. (ekstern lenke)
• Kvinnsland, Yngve; Muren, Ludvig Paul; Dahl, Olav (2004). A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of the equivalent uniform doses and the volume parameter. (ekstern lenke)
• Sagstuen, Hege; Aass, Nina; Fosså, Sophie D et al. (2004). Blood pressure and Body mass index in testicular cancer survivors. (ekstern lenke)
• Karlsdottir, Åsa; Muren, Ludvig Paul; Wentzel-Larsen, Tore et al. (2004). Dose response in a series of 495 patients with early prostate cancer. (ekstern lenke)
• Muren, Ludvig Paul; Karlsdottir, Åsa; Kvinnsland, Yngve et al. (2004). A test of the ICRU 62 "Planning organ at Risk Volume" concept for the rectum. (ekstern lenke)
• Brydøy, Marianne; Fossa, S; Klepp, Olbjørn et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Brydøy, Marianne; Fossa, S.; Klepp, O. et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Dahl, Olav; Tveit, Kjell Magne; Carlsen, Erik et al. (2003). Only colon cancer patients with Dukes stage C benefit from adjuvant chemotherapy with 5-fluorouracil and levamisole among 425 patients with operable colorectal cancer in a Norwegian randomised study. (ekstern lenke)
• Glimelius, Bengt; Cedermark, B.; Dahl, Olav et al. (2003). Adjuvant chemotherapy in colorectal cancer: Joint analyses of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. (ekstern lenke)
• Westermann, Anneke M.; Jones, Ellen; Schem, Baard-Christian et al. (2003). Regional hyperthermia added to chemoradiotherapy in advanced cervical cancer: Multicenter international feasibility. (ekstern lenke)
• Muren, Ludvig; Maurstad, Gjertrud; Hafslund, Rune et al. (2001). Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. (ekstern lenke)
• Knutsen, S; Hafslund, Rune; Monge, Odd R et al. (2001). Verification of a 3-D treatment planning system for episcleral brachytherapy. (ekstern lenke)

Short communication

• Krohn, Jørgen Gitlesen; Dahl, Olav; Nybø, Tone et al. (2014). Brachytherapy for malignant uveal melanoma. (ekstern lenke)

Poster

• Grotmol, Tom; Karlsson, Robert; Kristiansen, Wenche et al. (2013). Investigation of six testicular germ cell tumor susceptibility genes reveals a parent-of-origin effect in SPRY4. (ekstern lenke)
• Kristiansen, Wenche; Andreassen, Kristine Engen; Karlsson, Robert et al. (2013). Genetic variation in AKT1, PTEN, and in the 8q24 locus, and the risk of testicular germ cell tumor. (ekstern lenke)
• Karlsson, Robert; Kristiansen, Wenche; Andreassen, Kristine Engen et al. (2012). Validation, fine-mapping, and characterization of six genes related to testicular germ cell tumour in a large Swedish-Norwegian population. (ekstern lenke)
• Kristiansen, Wenche; Andreassen, Kristine Engen; Karlsson, Robert et al. (2012). Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: A case-parent triad study in a Norwegian-Swedish population. (ekstern lenke)
• Sagstuen, Hege; Aass, Nina; Fosså, Sophie et al. (2005). Metabolic syndrom in long-term testicular cancer survivors. (ekstern lenke)
• Sagstuen, Hege; Aass, Nina; Fosså, Sophie D. et al. (2005). Metabolic syndrome in long-term testicular cancer survivors. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie Dorothea; Klepp, Olbjørn et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Balteskard, Lise; Bremnes, Roy Martin; Dahl, Olav et al. (2004). Working ability and educational level among long-term survivors of testicular cancer (TCSS) compared to a general population (genPop). (ekstern lenke)
• Karlsdottir, Åsa; Johannessen, Dag Clement; Muren, Ludvig Paul et al. (2004). Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. (ekstern lenke)
• Muren, Ludvig Paul; Karlsdottir, Åsa; Kvinnsland, Yngve et al. (2004). Testing the new ICRU 62 "Planning organ at risk volume" concept for the rectum. (ekstern lenke)
• Brydøy, Marianne; Fosså, Sophie D; Klepp, Olbjørn et al. (2004). Post-treatment paternity in testicular cancer survivors. (ekstern lenke)
• Sørbye, Halfdan; Glimelius, Bengt; Berglund, Åke et al. (2003). Nordic 5-fluorouracil/folinic acid bolus schedule combined with oxaliplatin (FLOX) as first-line treatment to metastatic colorectal cancer. (ekstern lenke)
• Klepp, Olbjørn; Dahl, Olav; Cavallin-Stahl, E et al. (2003). Risk-adapted brief adjuvant chemotherapy in clinical stage I (CSI) nonseminomatous germ cell testicular cancer (NSGCT). (ekstern lenke)
• Muren, Ludvig; Mella, Olav; Hafslund, R. et al. (2001). National survey of IMRT expectations in Norway. (ekstern lenke)
• Dahl, Olav; Dæhlin, L.; Maartmann-Moe, H. et al. (2001). Improved survival in patients with testicula germ cell tumors. (ekstern lenke)
• Knutsen, S.; Hafslund, Rune; Monge, Odd R et al. (2001). Dosimetric verification of a dedicated 3-D treatment planning system for episcleral plaque therapy. (ekstern lenke)
• Schem, Baard-Christian; Frøystein, T.; Hjertaker, B. T. et al. (2001). Regional Hyperthermia as part of trimodality treatment of locally advanced/locally recurrent cervical carcinoma, and primarily inoperable/locally recurrent carcinoma. (ekstern lenke)

Rapport

• Lehne, Gustav; Angelsen, Anders; Langberg, Carl W. et al. (2011). Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av testikkelkreft. (ekstern lenke)
• Kaasa, S.; Vatten, L.; Vassenden, A. et al. (2007). Kvalitetsregistre over kreftsykdommer. (ekstern lenke)
• Johansen, Truls Bjerklund; Dahl, Olav; Heikilã, Reino et al. (2002). Brachyterapy ved prostatakreft. Medisinsk metodevurdering basert på egen litteraturgjennomgang. (ekstern lenke)
• Lind, Gunnar; Dahl, Olav; Wist, Erik (1999). Stråleskader etter brystkreftbehandling ved Radiumhospitalet 1975-86 : rapport/Erstatningsutvalget for stråleskader. (ekstern lenke)
• Tveit, KM; Bergan, A.; Dahl, Olav et al. (1999). Kolorektalcancer og analcancer. En veiledning for leger. (ekstern lenke)
• Lind, Gunnar; Dahl, Olav; Wist, Erik (1998). Erstatningsutvalget for stråleskader. Stråleskader etter brystkreftbehandling ved Radiumhospitalet 1975-86. (ekstern lenke)
• Lind, G.; Dahl, Olav; Wist, E. (1998). Erstatningsutvalget for stråleskader. Stråleskader etter brystkreftbehandling ved Radiumhospitalet 1975-86. (ekstern lenke)
• Fosså, Sophie D.; Dæhlin, Lars; Tveter, K et al. (1994). Maligne tumores i binyre, nyre, ureter, blære og prostata. (ekstern lenke)

Annet

• Thoresen, G. Hege; Dahl, Olav; Christoffersen, Thoralf (2010). L2 Legemidler i behandlingen av kreftsykdommer. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Christoffersen, Thoralf; Guren, Tormod K.; Spindler, Karen-Lise Garm et al. (2009). Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues. (ekstern lenke)
• Dahl, Olav; Fluge, Øystein (2008). Analkreft. (ekstern lenke)
• Muren, Ludvig Paul; Småland, Rune; Dahl, Olav (2004). Conformal radiotherapy of urinary bladder cancer. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Dahl, Olav; Kvaløy, Stein Olav; Lehne, Gustav et al. (2009). Medikamentell kreftbehandling. (ekstern lenke)
• Dahl, Olav; Lehne, Gustav (2009). Cancer testis. (ekstern lenke)
• Tveit, KM; Balteskard, L; Dahl, Olav (2009). Gastrointestinal kreft. (ekstern lenke)
• Dahl, Olav; Nygaard, R; Lehne, Gustav et al. (2009). Bivirkninger. (ekstern lenke)
• Christoffersen, Thoralf; Fluge, Øystein; Lehne, Gustav et al. (2009). Kreftceller og kjemoterapi. (ekstern lenke)
• Dahl, Olav; Kvaløy, Stein; Lehne, Gustav et al. (2009). Medikamentell kreftbehandling. (ekstern lenke)
• Christoffersen, Thoralf; Fluge, Øystein; Lehne, Gustav et al. (2009). Kreftceller og kjemoterapi. (ekstern lenke)
• Dahl, Olav; Nygaard, Randi; Christoffersen, Thoralf et al. (2009). Bivirkninger. (ekstern lenke)
• Dahl, Olav; Lilleby, W; Helle, Svein inge et al. (2009). Kreft i nyre, ureter, urinblære og prostata. (ekstern lenke)
• Christoffersen, Thoralf; Dahl, Olav (2007). Kreftsykdommer. (ekstern lenke)
• Christoffersen, Thoralf; Dahl, Olav (2007). Legemidler i behandlingen av kreftsykdommer. (ekstern lenke)
• Christoffersen, Thoralf; Dahl, Olav (2004). Legemidler i behandling av kreftsykdommer. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf (2004). Kreftsykdommer. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf (2004). Kreftsykdommer. (ekstern lenke)
• Christoffersen, Thoralf; Dahl, Olav (2004). Legemidler i behandlingen av kreftsykdommer. (ekstern lenke)
• Dahl, Olav; Overgaard, Jens (2001). Hyperthermia. (ekstern lenke)
• Dahl, Olav (2001). Høyvoltanlegget ved Haukeland Sykehus. (ekstern lenke)
• Klepp, Olbjørn; Norum, Jan; Dahl, Olav et al. (1999). Testikkelkreft. (ekstern lenke)
• Sigurdsson, F; Cunningham, D; Dahl, Olav et al. (1999). Adjuvant chemotherapy for colorectal cancer. (ekstern lenke)
• Dahl, Olav; Christoffersen, T; Kvaløy, Stein O et al. (1999). Medikamentell kreftbehandling. (ekstern lenke)
• Tveit, KM; Giercksky, K-E; Dahl, Olav (1999). Gastrointestinal kreft. (ekstern lenke)
• Tveit, KM; Dahl, Olav; Kvaløy, Stein O (1999). Behandling med cytostatica. (ekstern lenke)
• Tveit, Kjell Magne; Bergan, A.; Dahl, Olav et al. (1999). Kolorektalcancer og analcancer. (ekstern lenke)
• Dahl, Olav; Aass, N; Christoffersen, T (1999). Bivirkninger. (ekstern lenke)
• Klepp, O; Norum, J; Dahl, Olav et al. (1999). Testikkelkreft. (ekstern lenke)
• Christoffersen, T; Fodstad, Ø; Smeland, EB et al. (1999). Kreftceller og kjemoterapi. (ekstern lenke)
• Dahl, Olav (1995). Interaction of heat and drugs in vitro and in vivo. (ekstern lenke)

Lærebok

• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein O et al. (1999). Cytostatika. Medikamentell kreftbehandling [6. utg.]. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Dahl, Olav; Christoffersen, Thoralf; Kvaløy, Stein et al. (1999). Cytostatika. Medikamentell kreftbehandling. (ekstern lenke)
• Dahl, O; Christoffersen, Thoralf; Kvaløy, Stein (1999). Cytostatika. (ekstern lenke)

Kronikk

• Dahl, Olav (1998). Greetings from the president of the International Association for Hyperthermic Oncology. (ekstern lenke)
• Dahl, Olav (1998). Arbiter. (ekstern lenke)
• Dahl, Olav (1998). Current Controversies in Cancer. Should systematic lymph node dissection be recommended for gastric cancer?. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin